Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Neuroepithelial

Explore clinical trials studying Neoplasms, Neuroepithelial. Study availability and eligibility vary by location and protocol.

2,953 public trials 645 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Neuroepithelial trial results

Completed

H3.3K27M Peptide Vaccine With Nivolumab for Children With Newly Diagnosed DIPG and Other Gliomas

NCT02960230

Conditions
Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +16 more
Locations
  • Rady Children's Hospital-San Diego San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
View all 15 locations
View Trial Details
Completed

Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas

NCT02323880

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +29 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Medical Center-Mission Bay San Francisco, California, United States
View all 23 locations
View Trial Details
Completed

BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations

NCT03914742

Conditions
Astrocytoma, Glioblastoma, Glioma, +12 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • Yale University New Haven, Connecticut, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
View Trial Details
Completed

Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma

NCT01849146

Conditions
Astrocytoma, Glioblastoma, Glioma, +8 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • UCSF Medical Center-Parnassus San Francisco, California, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
View Trial Details
Completed

Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma

NCT01553149

Conditions
Astrocytoma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, +31 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
View all 126 locations
View Trial Details

Related conditions